Ryvu Therapeutics SA (RVU) — Free Cash Flow Generation Index

Latest as of December 2022: 0.93x

Ryvu Therapeutics SA (RVU) has a Free Cash Flow Generation Index of 0.93x as of December 2022. Free cash flow of zł55.70 Million represents 1% of operating cash flow (zł59.92 Million). Read RVU total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.93x
Free Cash Flow / Operating CF

Free Cash Flow

zł55.70 Million
PLN

Operating Cash Flow

zł59.92 Million
PLN

Capital Expenditures

zł4.22 Million
PLN

Ryvu Therapeutics SA Free Cash Flow Generation Index (2017–2022)

Historical FCF Generation Index trend for Ryvu Therapeutics SA across 2 annual periods. Explore Ryvu Therapeutics SA capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Ryvu Therapeutics SA (2017–2022)

Year-by-year Free Cash Flow Generation Index for Ryvu Therapeutics SA. For the full company profile including market capitalisation, see Ryvu Therapeutics SA market capitalisation.

Year FCG Index Free Cash Flow (PLN) Operating CF Capital Expenditures YoY Change
2022 0.56x zł12.03 Million zł21.32 Million zł9.29 Million ▲ +158.6%
2017 -0.96x zł-10.58 Million zł10.98 Million zł21.56 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).